Endothelial cells augment the suppressive function of CD4+ CD25+Foxp3+ regulatory T cells: Involvement of programmed death-1 and IL-10

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5562-5570

  Bedke, Tanja ^a,b   Pretsch, Leah ^a   Karakhanova, Svetlana ^a   Enk, Alexander H ^a   Mahnke, Karsten ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; PROGRAMMED DEATH 1 RECEPTOR; RECEPTOR PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; APOPTOSIS REGULATORY PROTEIN; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA; MEMBRANE ANTIGEN; PDCD1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL COMMUNICATION; CELL CULTURE; CELL MOTION; CYTOLOGY; IMMUNOLOGY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LUNG; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; SECRETION; UPREGULATION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 77954700764     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902458     Document Type: Article

References (48)

1. Shevach, E. M., R. S. McHugh, C. A. Piccirillo, and A. M. Thornton. 2001. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol. Rev. 182: 58-67.
2. Itoh, M., T. Takahashi, N. Sakaguchi, Y. Kuniyasu, J. Shimizu, F. Otsuka, and S. Sakaguchi. 1999. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162: 5317-5326. (Pubitemid 29307138)
3. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
4. Groux, H., A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J. E. de Vries, and M. G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
5. Zhang, X., D. N. Koldzic, L. Izikson, J. Reddy, R. F. Nazareno, S. Sakaguchi, V. K. Kuchroo, and H. L. Weiner. 2004. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 16: 249-256.
6. Piccirillo, C. A., M. Tritt, E. Sgouroudis, A. Albanese, M. Pyzik, and V. Hay. 2005. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Ann. N. Y. Acad. Sci. 1051: 72-87.
7. Godfrey, V. L., J. E. Wilkinson, and L. B. Russell. 1991. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138: 1379-1387.
8. Huter, E. N., G. A. Punkosdy, D. D. Glass, L. I. Cheng, J. M. Ward, and E. M. Shevach. 2008. TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice. Eur. J. Immunol. 38: 1814-1821.
9. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
10. Raimondi, G., W. J. Shufesky, D. Tokita, A. E. Morelli, and A. W. Thomson. 2006. Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells. J. Immunol. 176: 2808-2816. (Pubitemid 43306940)
11. Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11: 141-151.
12. Okazaki, T., and T. Honjo. 2007. PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 19: 813-824.
13. Liang, S. C., Y. E. Latchman, J. E. Buhlmann, M. F. Tomczak, B. H. Horwitz, G. J. Freeman, and A. H. Sharpe. 2003. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33: 2706-2716.
14. Totsuka, T., T. Kanai, S. Makita, R. Fujii, Y. Nemoto, S. Oshima, R. Okamoto, A. Koyanagi, H. Akiba, K. Okumura, et al. 2005. Regulation of murine chronic colitis by CD4+CD25- programmed death-1+ T cells. Eur. J. Immunol. 35: 1773-1785.
15. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
16. Huehn, J., and A. Hamann. 2005. Homing to suppress: address codes for Treg migration. Trends Immunol. 26: 632-636.
17. Dudda, J. C., N. Perdue, E. Bachtanian, and D. J. Campbell. 2008. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205: 1559-1565.
18. Suffia, I. J., S. K. Reckling, C. A. Piccirillo, R. S. Goldszmid, and Y. Belkaid. 2006. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203: 777-788.
19. Linehan, D. C., and P. S. Goedegebuure. 2005. CD25+ CD4+ regulatory T-cells in cancer. Immunol. Res. 32: 155-168.
20. Austrup, F., D. Vestweber, E. Borges, M. Löhning, R. Bräuer, U. Herz, H. Renz, R. Hallmann, A. Scheffold, A. Radbruch, and A. Hamann. 1997. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 385: 81-83.
21. Chaplin, D. D. 2002. Cell cooperation in development of eosinophil-predominant inflammation in airways. Immunol. Res. 26: 55-62.
22. Pober, J. S., and W. C. Sessa. 2007. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7: 803-815.
23. Kreisel, D., A. M. Krasinskas, A. S. Krupnick, A. E. Gelman, K. R. Balsara, S. H. Popma, M. Riha, A. M. Rosengard, L. A. Turka, and B. R. Rosengard. 2004. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection. J. Immunol. 173: 3027-3034.
24. Krupnick, A. S., A. E. Gelman, W. Barchet, S. Richardson, F. H. Kreisel, L. A. Turka, M. Colonna, G. A. Patterson, and D. Kreisel. 2005. Murine vascular endothelium activates and induces the generation of allogeneic CD4+25+Foxp3+ regulatory T cells. J. Immunol. 175: 6265-6270.
25. Marelli-Berg, F. M., E. Peek, E. A. Lidington, H. J. Stauss, and R. I. Lechler. 2000. Isolation of endothelial cells from murine tissue. J. Immunol. Methods 244: 205-215.
26. Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26: 677-704.
27. Zhang, N., B. Schröppel, G. Lal, C. Jakubzick, X. Mao, D. Chen, N. Yin, R. Jessberger, J. C. Ochando, Y. Ding, and J. S. Bromberg. 2009. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30: 458-469.
28. McLachlan, J. B., D. M. Catron, J. J. Moon, and M. K. Jenkins. 2009. Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity 30: 277-288.
29. Ring, S., S. C. Schäfer, K. Mahnke, H. A. Lehr, and A. H. Enk. 2006. CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur. J. Immunol. 36: 2981-2992.
30. Enarsson, K., B. S. Lundin, E. Johnsson, T. Brezicka, and M. Quiding-Järbrink. 2007. CD4+ CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients. Eur. J. Immunol. 37: 282-291.
31. Nummer, D., E. Suri-Payer, H. Schmitz-Winnenthal, A. Bonertz, L. Galindo, D. Antolovich, M. Koch, M. Büchler, J. Weitz, V. Schirrmacher, and P. Beckhove. 2007. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma. J. Natl. Cancer Inst. 99: 1188-1199.
32. Tang, Q., and J. A. Bluestone. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244.
33. Keir, M. E., S. C. Liang, I. Guleria, Y. E. Latchman, A. Qipo, L. A. Albacker, M. Koulmanda, G. J. Freeman, M. H. Sayegh, and A. H. Sharpe. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203: 883-895.
34. Latchman, Y. E., S. C. Liang, Y. Wu, T. Chernova, R. A. Sobel, M. Klemm, V. K. Kuchroo, G. J. Freeman, and A. H. Sharpe. 2004. PD-L1 deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA 113: 10691-10696.
35. Fife, B. T., I. Guleria, M. Gubbels Bupp, T. N. Eagar, Q. Tang, H. Bour-Jordan, H. Yagita, M. Azuma, M. H. Sayegh, and J. A. Bluestone. 2006. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 203: 2737-2747.
36. Cheng, X., Z. Zhao, E. Ventura, B. Gran, K. S. Shindler, and A. Rostami. 2007. The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma. J. Neuroimmunol. 185: 75-86. (Pubitemid 46497444)
37. Magnus, T., B. Schreiner, T. Korn, C. Jack, H. Guo, J. Antel, I. Ifergan, L. Chen, F. Bischof, A. Bar-Or, and H. Wiendl. 2005. Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J. Neurosci. 25: 2537-2546.
38. Baecher-Allan, C., J. A. Brown, G. J. Freeman, and D. A. Hafler. 2003. CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Found. Symp. 252: 67-88, discussion 88-91, 106-114.
39. Baecher-Allan, C., J. A. Brown, G. J. Freeman, and D. A. Hafler. 2001. CD4+CD25 high regulatory cells in human peripheral blood. J. Immunol. 167: 1245-1253.
40. Polanczyk, M. J., C. Hopke, A. A. Vandenbark, and H. Offner. 2007. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int. Immunol. 19: 337-343.
41. Kitazawa, Y., M. Fujino, Q. Wang, H. Kimura, M. Azuma, M. Kubo, R. Abe, and X. K. Li. 2007. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Transplantation 83: 774-782.
42. Wei, S., A. B. Shreiner, N. Takeshita, L. Chen, W. Zou, and A. E. Chang. 2008. Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta. Cancer Res. 68: 5432-5438.
43. Yang, Z. Z., A. J. Novak, M. J. Stenson, T. E. Witzig, and S. M. Ansell. 2006. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107: 3639-3646.
44. Brooks, D. G., S.-J. Ha, H. Elsaesser, A. H. Sharpe, G. J. Freeman, and M. B. A. Oldstone. 2008. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc. Natl. Acad. Sci. USA 105: 20428-20433.
45. Eppihimer, M. J., J. Gunn, G. J. Freeman, E. A. Greenfield, T. Chernova, T. Erickson, and J. P. Leonard. 2002. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Mircrocirculation 9: 133-145.
46. Szymczak-Workman, A. L., C. J. Workman, and D. A. Vignali. 2009. Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. J. Immunol. 182: 5188-5192.
47. Haag, F., S. Adriouch, A. Braß, C. Jung, S. Möller, F. Scheuplein, P. Bannas, M. Seman, and F. Koch-Nolte. 2007. Extracellular NAD and ATP: Partners in immune cell modulation. Purinergic Signal. 3: 71-81.
48. Sevigny, C. P., L. Li, A. S. Awad, L. Huang, M. McDuffie, J. Linden, P. I. Lobo, and M. D. Okusa. 2007. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J. Immunol. 178: 4240-4249.